Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

8.90
Delayed Data
As of 3:59pm ET
 +0.17 / +1.95%
Today’s Change
6.00
Today|||52-Week Range
13.18
-14.91%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 19.50, with a high estimate of 24.00 and a low estimate of 16.00. The median estimate represents a +119.10% increase from the last price of 8.90.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$8.4M
Reporting Date
Oct 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.15%
 
 
 
 
 
 
Growthannually -33.68%
 
 
 
 
 
 

Sales

Growthquarterly 45.48%
 
 
 
 
 
 
Growthannually 5.11%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.